|
|
June 30, 2020
| Focus Feature: Focused Ultrasound and Cancer Immunotherapy |
| Focused Ultrasound and Cancer Immunotherapy |
The Focused Ultrasound Foundation recognizes that the intersection of focused ultrasound and cancer immunotherapy offers a highly promising opportunity for combination approaches to treat a variety of cancers. Through our Cancer Immunotherapy Program and collaboration with our partners and the research community, we aim to explore and assess the full potential of focused ultrasound to turn this promise into reality.
It’s been five years since the Foundation formally launched our Cancer Immunotherapy Program. Now, as the Cancer Research Institute’s 8th annual Cancer Immunotherapy Month™ comes to a close, we are pleased to highlight important progress that has been made in the field and key Foundation activities in this flagship program. Our efforts have helped push the field forward, and we continue to work diligently toward a future immune to cancer.
|
| READ MORE > |
|
|
|
|
|
|
|
|
|
 |
Cancer Immunotherapy Treatment and Research in a COVID-19 World
Jill O’Donnell-Tormey, PhD, CEO of the Cancer Research Institute (CRI), and the Foundation's Chief Scientific Officer, Jessica Foley, PhD, discuss cancer immunotherapy and the ways that CRI and the Foundation are working together to advance exciting research, through a lens of the COVID-19 environment (60 minutes). |
|
|
|
|
|
|
Immunotherapy Research Overview
New and ongoing clinical and preclinical research is examining the use of focused ultrasound in initiating an anti-tumor immune response – either alone or in combination with immunotherapies – to treat cancer.
READ MORE > |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
